Group One Trading
TNXP icon

Group One Trading’s Tonix Pharmaceuticals TNXP Stock Holding History

Group One Trading’s Portfolio TNXP Stock Details TNXP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$108K Buy
8,500
+400
+5% +$5.16K ﹤0.01% 4785
2026
Q1 		$111K Buy
8,100
+1,700
+27% +$26.2K ﹤0.01% 4630
2025
Q4 		$100K Buy
6,400
+3,600
+129% +$66.4K ﹤0.01% 5011
2025
Q3 		$67.6K Buy
+2,800
New +$104K ﹤0.01% 5712
2016
Q3 		– Hold
0
– -$8K – 4907
2016
Q2 		– Hold
0
– – – 4153
2016
Q1 		– Hold
0
– – – 4018
2015
Q4 		– Hold
0
– – – 3622
2015
Q3 		– Hold
0
– – – 3802
2015
Q2 		– Hold
0
– – – 2951
2015
Q1 		– Hold
0
– – – 4234
2014
Q4 		– Hold
0
– -$80K – 5273
2014
Q3 		– Hold
0
– – – 3189
2014
Q2 		– Hold
0
– – – 2593

Other funds holding TNXP

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
JHC
Jones Hill Capital New York $470M AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
II
Ishara Investments Los Angeles, California $136M AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Group One Trading's TNXP Position: Q2 2026 in Review

Group One Trading reduced its Tonix Pharmaceuticals (TNXP) stake by 67% in Q2 2026, selling an estimated $6.54K and leaving 253 shares worth $3.23K. The position accounts for ﹤0.01% of the portfolio, ranked #6893.

Group One Trading first reported a position in TNXP in Q3 2025 and has held it in 4 quarters since. The position peaked at $25.9K in Q4 2025. 103 funds tracked by Wall St. Rank hold TNXP as of Q2 2026.

  • Group One Trading held 253 shares of Tonix Pharmaceuticals worth $3.23K as of Q2 2026.
  • Group One Trading sold 507 Tonix Pharmaceuticals shares in Q2 2026, an estimated $6.54K.
  • Tonix Pharmaceuticals made up ﹤0.01% of Group One Trading's portfolio in Q2 2026, its #6893 holding.
  • Group One Trading first reported a position in Tonix Pharmaceuticals in Q3 2025 and has held it in 4 quarters since.
  • Group One Trading's Tonix Pharmaceuticals position peaked at $25.9K in Q4 2025.
  • 103 funds tracked by Wall St. Rank held Tonix Pharmaceuticals as of Q2 2026.

Based on Group One Trading's 13F filing for Q2 2026, filed 14 Aug 2026.